Opportunity Information: Apply for PA 07 092

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Collaborative R01s for Clinical and Services Studies of Mental Disorders, AIDS and Alcohol Use Disorders (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants 93.273 Alcohol Research Programs.
  • This funding opportunity was created on Jan 26, 2009 and posted on Nov 27, 2006.
  • Applicants must submit their applications by May 8, 2009 Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Public housing authorities/Indian housing authorities Others (see text field entitled Additional Information on Eligibility for clarification) For profit organizations other than small businesses Independent school districts Private institutions of higher education County governments State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Small businesses Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
  • Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith based or community based organizations can apply.
Apply for PA 07 092

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

This NIH funding opportunity, led by the National Institute of Mental Health (NIMH) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA), is designed to support collaborative, multi-site clinical and services research projects that cannot be completed at a single location. The central idea is to fund linked R01 research projects that work together under a shared, well-defined protocol so investigators can enroll enough participants, recruit faster, and include more diverse and representative samples than would be possible in a single-site study. The announcement is aimed especially at intervention trials focused on treatment, prevention, or rehabilitation for people with mental disorders, alcohol use disorders, and co-occurring mental and alcohol problems, but it also welcomes other collaborative clinical studies that address related public health needs.

The scientific scope is intentionally broad as long as the work is clinically oriented and benefits from multi-site collaboration. In addition to intervention trials, the FOA highlights areas such as mental health services research (for example, studies of access, quality, implementation, and outcomes in real-world care), HIV/AIDS-related clinical and services studies, genetics, psychopathology, stigma, and cultural and social processes that shape risk, engagement in care, and outcomes. The unifying feature is that the research should be structured in a way where having two or more sites is essential to meeting the aims, whether that is because the target population is hard to reach, the study requires a larger sample size for statistical power, the investigators need to test the protocol across distinct settings, or the project seeks to ensure adequate inclusion of underrepresented groups.

The program uses the NIH Research Project Grant (R01) mechanism, but it is specifically set up for "linked" collaborative R01 applications. Each participating site submits its own R01 application with its own Project Director/Principal Investigator, and each application represents an essential piece of the overall study rather than a standalone project. In multi-site clinical trials, it is expected that the same core protocol will be implemented across all sites, which helps ensure that data can be combined and compared in a rigorous way. At the same time, the FOA recognizes that some responsibilities may be specialized at particular sites, such as centralized data coordination, database development and maintenance, intervention fidelity monitoring, quality assurance, statistical analysis, or preparation of cross-site reporting.

For studies involving many sites, the FOA anticipates that one application will typically function as a coordinating site. That coordinating site would handle functions that are more efficient and consistent when centralized, such as data management systems, common training procedures, harmonized quality control processes, monitoring of protocol adherence, and overall project administration. The linked structure is meant to formalize cross-site coordination so that recruitment targets, data definitions, outcome measures, analytic plans, and reporting timelines stay aligned across all partners.

A notable feature of this opportunity is its openness to partnerships that extend beyond academic medical centers and universities. The FOA explicitly supports collaborations between universities or colleges and community-based organizations, including consumer and advocacy groups, as well as state or local governments and Tribal governments. These arrangements are encouraged when partners bring complementary expertise, such as community trust and practical service-delivery knowledge paired with academic research capacity, evaluation methods, and infrastructure. The expectation is that multi-site collaborations in these settings will strengthen relevance, feasibility, and real-world impact, particularly for populations that are often underserved or overlooked in traditional clinical research.

While the default award mechanism is the R01, the announcement also flags a possibility that matters for applicants planning governance and oversight. After peer review, and depending on the scientific needs and the level of NIH staff involvement required, NIMH may decide to convert a linked set of collaborative R01 applications into cooperative agreement mechanisms (U01 or U10). In practice, that means NIH staff may take a more substantial programmatic role in the conduct and coordination of the study than is typical for an R01, which can affect expectations around decision-making structures, milestones, and oversight.

From an eligibility standpoint, the FOA is inclusive. Eligible applicants include a wide range of U.S. entities such as public and private institutions of higher education, nonprofits (including those with and without 501(c)(3) status), for-profit organizations (including small businesses), independent school districts, and various levels of government (city/township, county, state, special district), as well as Tribal governments and other Tribal organizations. Public housing authorities and Indian housing authorities are also listed. The announcement further clarifies that foreign institutions may apply, that eligible federal agencies may apply, and that faith-based and community-based organizations are eligible, which aligns with the FOA's emphasis on multi-sector partnerships.

Administratively, this opportunity is identified as PA-07-092 under NIH, categorized as discretionary grant funding in the health area, with no cost sharing or matching requirement. It is tied to CFDA programs 93.242 (Mental Health Research Grants) and 93.273 (Alcohol Research Programs). The posting date is listed as November 27, 2006, with multiple receipt dates over its active period and an archive date of June 8, 2009, meaning it was time-limited and is now closed. The full announcement was hosted through the NIH grants guide, and NIH provided webmaster contacts for access or linking issues.

Overall, the FOA is best understood as a framework for running rigorous, coordinated, multi-site clinical and services studies where shared methods across sites are essential. It is built for teams that can agree on a common protocol, coordinate recruitment and implementation across locations, and manage the practical realities of cross-site data harmonization, quality control, and analysis, while also encouraging meaningful collaborations with community and government partners to improve reach and impact.

Frequently Asked Questions (FAQs)

What is this NIH funding opportunity about?

This opportunity supports collaborative, multi-site clinical and services research projects that cannot be completed at a single location. The intent is to fund linked R01 research projects that operate under a shared, well-defined protocol so teams can recruit faster, enroll enough participants, and include more diverse and representative samples than a single-site study would allow.

Which NIH Institutes lead this opportunity?

The opportunity is led by the National Institute of Mental Health (NIMH) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA).

What kinds of studies are especially encouraged?

The announcement is aimed especially at intervention trials focused on treatment, prevention, or rehabilitation for people with mental disorders, alcohol use disorders, and co-occurring mental and alcohol problems. It also welcomes other collaborative clinical studies that address related public health needs, as long as the work is clinically oriented and benefits from multi-site collaboration.

Is the scientific scope narrow or broad?

The scientific scope is intentionally broad, provided the research is clinically oriented and gains clear advantages from being conducted across two or more sites.

Besides intervention trials, what areas does the FOA highlight?

In addition to intervention trials, the FOA highlights mental health services research (such as studies of access, quality, implementation, and outcomes in real-world care), HIV/AIDS-related clinical and services studies, genetics, psychopathology, stigma, and cultural and social processes that influence risk, engagement in care, and outcomes.

What makes a project a good fit for a multi-site approach under this FOA?

The key requirement is that having two or more sites is essential to meeting the study aims. Examples include: the target population is hard to reach, a larger sample size is needed for statistical power, the protocol needs testing across distinct settings, or the study is designed to ensure adequate inclusion of underrepresented groups.

What grant mechanism is used?

The program uses the NIH Research Project Grant (R01) mechanism, specifically structured for linked, collaborative R01 applications.

What does "linked" R01 mean in this context?

Each participating site submits its own R01 application with its own Project Director/Principal Investigator. Each application is an essential part of the overall study and is not intended to function as a standalone project.

Do all sites need to use the same protocol?

In multi-site clinical trials, it is expected that the same core protocol will be implemented across all sites. This supports rigorous combination and comparison of data across locations.

Can different sites have specialized roles even if the protocol is shared?

Yes. The FOA recognizes that some responsibilities may be specialized at particular sites, including centralized data coordination, database development and maintenance, intervention fidelity monitoring, quality assurance, statistical analysis, or preparation of cross-site reporting.

Is a coordinating site expected?

For studies involving many sites, the FOA anticipates that one application will typically function as a coordinating site to handle centralized functions that are more efficient and consistent when managed in one place.

What functions might a coordinating site manage?

Examples include data management systems, common training procedures, harmonized quality control processes, monitoring of protocol adherence, and overall project administration.

Why does the FOA emphasize formal cross-site coordination?

The linked structure is meant to keep recruitment targets, data definitions, outcome measures, analytic plans, and reporting timelines aligned across all participating partners.

Are collaborations limited to universities and academic medical centers?

No. The FOA explicitly supports collaborations that extend beyond academic settings, including partnerships with community-based organizations, consumer and advocacy groups, state or local governments, and Tribal governments.

Why are community and government partnerships encouraged?

These partnerships are encouraged when collaborators bring complementary strengths, such as community trust and service-delivery knowledge paired with academic research capacity, evaluation methods, and research infrastructure. The expectation is that these collaborations can strengthen relevance, feasibility, and real-world impact, particularly for underserved populations.

Can foreign institutions apply?

Yes. The FOA states that foreign institutions may apply.

Can federal agencies apply?

Yes. The FOA states that eligible federal agencies may apply.

What types of U.S. organizations are eligible to apply?

Eligibility includes many U.S. entities, such as public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations (including small businesses), independent school districts, and multiple levels of government (city/township, county, state, special district). Tribal governments and other Tribal organizations, as well as public housing authorities and Indian housing authorities, are also listed as eligible.

Are faith-based and community-based organizations eligible?

Yes. The FOA clarifies that faith-based and community-based organizations are eligible, consistent with its emphasis on multi-sector partnerships.

Is cost sharing or matching required?

No. The FOA indicates there is no cost sharing or matching requirement.

What is the FOA identifier?

The opportunity is identified as PA-07-092.

What CFDA programs is this opportunity tied to?

It is tied to CFDA 93.242 (Mental Health Research Grants) and 93.273 (Alcohol Research Programs).

What is unusual about the award mechanism after peer review?

After peer review, and depending on scientific needs and the level of NIH staff involvement required, NIMH may decide to convert a linked set of collaborative R01 applications into cooperative agreement mechanisms (U01 or U10). This implies NIH staff may take a more substantial programmatic role than is typical for an R01, affecting expectations around decision-making structures, milestones, and oversight.

Is this funding opportunity still open?

No. The posting date is listed as November 27, 2006, and the archive date is June 8, 2009, indicating it was time-limited and is now closed.

Where was the full announcement hosted?

The full announcement was hosted through the NIH grants guide, and NIH provided webmaster contacts for access or linking issues.

What is the main takeaway for applicants considering this FOA?

This FOA is best understood as a framework for rigorous, coordinated, multi-site clinical and services studies where shared methods across sites are essential. It is designed for teams that can agree on a common protocol and manage cross-site recruitment, data harmonization, quality control, and analysis, while also supporting collaborations with community and government partners to improve reach and impact.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Innovations in Biomedical Computational Science and Technology Initiative (SBIR R43/R44)

Previous opportunity: Image Guided Cancer Interventions (SBIR R43/R44)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 07 092

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 07 092) also looked into and applied for these:

Funding Opportunity
Advanced Tools and Technologies for Deep Brain Stimulation in Movement Disorders STTR (R41/R42) Apply for PA 07 395

Funding Number: PA 07 395
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Computational Tools for Research in Neuroscience, Behavioral Science and Mental Health STTR R41/R42 Apply for PA 07 423

Funding Number: PA 07 423
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Computational Tools for Research in Neuroscience, Behavioral Science and Mental Health SBIR R43/R44 Apply for PA 07 424

Funding Number: PA 07 424
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
New Technology for Proteomics and Glycomics (SBIR R43/R44) Apply for PA 07 451

Funding Number: PA 07 451
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
New Technology for Proteomics and Glycomics (STTR R41/R42) Apply for PA 07 452

Funding Number: PA 07 452
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
High Throughput Tools for Brain and Behavior (SBIR R43/R44) Apply for PA 08 001

Funding Number: PA 08 001
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
High Throughput Tools for Brain and Behavior (STTR R41/R42) Apply for PA 08 002

Funding Number: PA 08 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development of PET and SPECT Ligands for Brain Imaging (SBIR R43/R44) Apply for PA 08 137

Funding Number: PA 08 137
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pharmacologic Agents and Drugs for Mental Disorders (SBIR R43/R44) Apply for PA 08 142

Funding Number: PA 08 142
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NINDS Cooperative Program in Translational Research Small Business Awards (SBIR U44) Apply for PAR 08 235

Funding Number: PAR 08 235
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
State Implementation Grants for Integrated Community Systems for CSHCN Apply for HRSA 09 159

Funding Number: HRSA 09 159
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $300,000
Part D Coordinated HIV Services and Access to Research for WICY One TimeSupplemental Funds Apply for HRSA 09 143

Funding Number: HRSA 09 143
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Development, Implementation and Evaluation of Strategies to Increase Vaccination of Adolescents Affiliated with a Medical Home (U01) Apply for RFA IP 09 006

Funding Number: RFA IP 09 006
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $550,000
Evaluation of New Technology to Improve Delivery of Immunizations (U01) Apply for RFA IP 09 005

Funding Number: RFA IP 09 005
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $225,000
NCMHD Endowment Program for Increasing Research and Institutional Resources Capacity in Section 736 Health Professions Schools (NCMHD Research Endowment Fund) (S21) Apply for RFA MD 09 002

Funding Number: RFA MD 09 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Extension of the World Trade Center Registry (U50) Apply for RFA OH 09 002

Funding Number: RFA OH 09 002
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $12,000,000
NCMHD Research Infrastructure in Minority Institutions (P20) Apply for RFA MD 09 003

Funding Number: RFA MD 09 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Community Based HIV/AIDS Prevention, Care and Support Apply for USAID UGANDA RFA 617 09 005

Funding Number: USAID UGANDA RFA 617 09 005
Agency: Agency for International Development
Category: Health
Funding Amount: $22,000,000
Pre Application for Dietary Supplement Research Centers Botanicals (X02) Apply for PAR 09 091

Funding Number: PAR 09 091
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
SECURING UGANDAS RIGHT TO ESSENTIAL MEDICINE Apply for USAID UGANDA RFA 617 09 001

Funding Number: USAID UGANDA RFA 617 09 001
Agency: Agency for International Development
Category: Health
Funding Amount: $40,000,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 092", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.